BioCentury | Mar 4, 2017
Product Development

Diagnosing AD trials

...see how the SNP signatures differ. Cytox has raised about £6 million ($7.4 million) from Spark Northwest Fund for Biomedical...
BioCentury | Sep 29, 2014
Financial News

Videregen completes venture financing

...U.K. Business: Transplant Date completed: 2014-09-25 Type: Venture financing Raised: L1.2 million ($2 million) Investors: Spark Northwest Fund for Biomedical...
BioCentury | Apr 7, 2014
Financial News

Cytox completes venture financing

...U.K. Business: Neurology Date completed: 4/3/14 Type: Venture financing Raised: £1.5 million ($2.5 million) Investors: Spark Northwest Fund for Biomedical...
Items per page:
1 - 3 of 3
BioCentury | Mar 4, 2017
Product Development

Diagnosing AD trials

...see how the SNP signatures differ. Cytox has raised about £6 million ($7.4 million) from Spark Northwest Fund for Biomedical...
BioCentury | Sep 29, 2014
Financial News

Videregen completes venture financing

...U.K. Business: Transplant Date completed: 2014-09-25 Type: Venture financing Raised: L1.2 million ($2 million) Investors: Spark Northwest Fund for Biomedical...
BioCentury | Apr 7, 2014
Financial News

Cytox completes venture financing

...U.K. Business: Neurology Date completed: 4/3/14 Type: Venture financing Raised: £1.5 million ($2.5 million) Investors: Spark Northwest Fund for Biomedical...
Items per page:
1 - 3 of 3